Results 31 to 40 of about 13,067 (200)
Frontiers in Pharmacology, 2018 Ibogaine is a potent psychedelic alkaloid that has been the focus of intense research because of its intriguing anti-addictive properties. According to anecdotic reports, ibogaine has been originally classified as an oneirogenic psychedelic; i.e ...
Joaquín González +10 more
doaj +1 more source
Frontiers in Neuroscience, 2018 Ever since the modern rediscovery of psychedelic substances by Western society, several authors have independently proposed that their effects bear a high resemblance to the dreams and dreamlike experiences occurring naturally during the sleep-wake cycle.
Camila Sanz +5 more
doaj +1 more source
6/ New perspectives in queer death studies
Whatever, 2021 This is part 6 of 6 of the dossier What do we talk about when we talk about queer death?, edited by M. Petricola. The contributions collected in this article seek to open new frontiers in queer death studies from the most diverse perspectives, from death
Alexandra Løvås Kristinnsdottir +6 more
doaj +1 more source
Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?
, 2020 This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject.
core +1 more source
Controlled Medical Use of Hallucinogens
, 2021 In the recent history of medical research, after several decades of dormancy, hallucinogens have regained their former status of being an object of interest for clinical research. Scientists view them as a powerful tool for gaining new insights about the
Guttmann, Marc Oliver Ladislaus
core
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species [PDF]
, 2020 Serotonergic hallucinogens such as lysergic acid diethylamide (LSD) induce head twitches in rodents via 5-HT(2A) receptor activation. The goal of the present investigation was to determine whether a correlation exists between the potency of hallucinogens
Halberstadt, Adam L +7 more
core +3 more sources
Pharmacokinetics and concentration-effect relationship of oral LSD in humans [PDF]
, 2015 BACKGROUND: The pharmacokinetics of oral lysergic acid diethylamide are unknown despite its common recreational use and renewed interest in its use in psychiatric research and practice.
Dolder, Patrick C. +4 more
core +1 more source
Cell Reports, 2021 Summary: Clinical evidence suggests that rapid and sustained antidepressant action can be attained with a single exposure to psychedelics. However, the biological substrates and key mediators of psychedelics’ enduring action remain unknown. Here, we show
Mario de la Fuente Revenga +12 more
doaj +1 more source
Frontiers in Neuroscience, 2018 Past research has demonstrated to the ability of psychedelics to enhance suggestibility, and pointed to their ability to amplify perception of meaning.
Ido Hartogsohn
doaj +1 more source
Frontiers in Psychiatry, 2017 Hallucinogen-persisting perception disorder (HPPD) is a syndrome characterized by prolonged or reoccurring perceptual symptoms, reminiscent of acute hallucinogen effects.
Laura Orsolini +9 more
doaj +1 more source